HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Orofacial granulomatosis as first manifestation of Crohn's disease: successful treatment of both conditions with a combination of infliximab and dapsone.

AuthorsNicole Kemmler, Norbert Pfannschmidt, Robert Strohal
JournalActa dermato-venereologica (Acta Derm Venereol) Vol. 92 Issue 4 Pg. 406-7 (Jul 2012) ISSN: 1651-2057 [Electronic] Sweden
PMID22113308 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Anti-Inflammatory Agents
  • Antibodies, Monoclonal
  • Dermatologic Agents
  • Dapsone
  • Infliximab
Topics
  • Adolescent
  • Anti-Inflammatory Agents (therapeutic use)
  • Antibodies, Monoclonal (therapeutic use)
  • Biopsy
  • Colonoscopy
  • Crohn Disease (complications, diagnosis, drug therapy)
  • Dapsone (therapeutic use)
  • Dermatologic Agents (therapeutic use)
  • Granulomatosis, Orofacial (diagnosis, drug therapy, etiology)
  • Humans
  • Infliximab
  • Male
  • Remission Induction
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: